Baker Hughes (BKR) Financials

$37.36 +0.68 (+1.85%)

Closing price 05/29/2025 04:00 PM Eastern

Extended Trading

$37.16 -0.20 (-0.55%)

As of 04:44 AM Eastern

Annual Income Statements for Baker Hughes

This table shows Baker Hughes' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	2,979	1,943	-601	-219	-9,940	128	195	-103	0.00	0.00
Consolidated Net Income / (Loss)	3,008	1,970	-578	-330	-15,761	271	283	-391	185	-631
Net Income / (Loss) Continuing Operations	3,008	1,970	-578	-330	-15,761	271	283	-391	185	-631
Total Pre-Tax Income	3,265	2,655	22	428	-15,202	753	680	-335	358	-158
Total Operating Income	3,081	2,317	1,185	1,310	-15,978	1,074	701	-284	457	-138
Total Gross Profit	5,840	5,251	4,400	4,049	3,199	4,432	3,986	3,036	2,932	4,495
Total Revenue	27,829	25,506	21,156	20,502	20,705	23,838	22,877	17,179	13,082	16,688
Total Cost of Revenue	21,989	20,255	16,756	16,453	17,506	19,406	18,891	14,143	10,150	12,193
Operating Cost of Revenue	21,989	20,255	16,756	16,453	17,506	19,406	18,891	14,143	10,150	12,193
Total Operating Expenses	2,759	2,934	3,215	2,739	19,043	3,358	3,285	3,320	2,475	4,633
Selling, General & Admin Expense	2,458	2,611	2,510	2,470	2,404	2,832	2,699	2,535	1,926	2,115
Impairment Charge	301	323	705	269	14,773	342	0.00	-	-	2,080
Total Other Income / (Expense), net	184	338	-1,163	-882	776	-321	-21	-51	-99	-20
Interest Expense	198	216	252	299	264	237	223	131	102	120
Other Income / (Expense), net	382	554	-911	-583	1,040	-84	202	80	3.00	100
Income Tax Expense	257	685	600	758	559	482	258	45	173	473
Net Income / (Loss) Attributable to Noncontrolling Interest	29	27	23	-111	-5,821	143	88	-330	-69	-25
Basic Earnings per Share	$3.00	$1.93	($0.61)	($0.27)	$0.00	$0.23	$0.46	($0.24)	$0.00	$0.00
Weighted Average Basic Shares Outstanding	990.11M	1.00B	1.01B	2.05B	1.04B	1.03B	427M	1.47B	-	-
Diluted Earnings per Share	$2.98	$1.91	($0.61)	($0.27)	($14.73)	$0.23	$0.45	($0.24)	$0.00	$0.00
Weighted Average Diluted Shares Outstanding	990.11M	1.00B	1.01B	2.05B	1.04B	1.03B	427M	1.47B	-	-
Weighted Average Basic & Diluted Shares Outstanding	990.11M	1.00B	1.01B	2.05B	1.04B	1.03B	427M	1.47B	-	-
Cash Dividends to Common per Share	$0.84	$0.78	$0.73	$0.72	$0.00	$0.72	$0.00	-	-	$0.00

This table shows Baker Hughes' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	402	1,179	766	579	455	439	518	410	576	183	-17
Consolidated Net Income / (Loss)	409	1,190	774	581	463	451	524	414	581	188	-9.00
Net Income / (Loss) Continuing Operations	409	1,190	774	581	463	451	524	414	581	188	-9.00
Total Pre-Tax Income	561	791	1,009	824	641	522	759	614	760	346	144
Total Operating Income	752	665	930	833	653	651	714	514	438	662	269
Total Gross Profit	1,475	1,530	1,542	1,490	1,278	1,448	1,343	1,311	1,149	1,336	1,124
Total Revenue	6,427	7,364	6,908	7,139	6,418	6,834	6,641	6,315	5,716	5,905	5,369
Total Cost of Revenue	4,952	5,834	5,366	5,649	5,140	5,386	5,298	5,004	4,567	4,569	4,245
Operating Cost of Revenue	4,952	5,834	5,366	5,649	5,140	5,386	5,298	5,004	4,567	4,569	4,245
Total Operating Expenses	723	865	612	657	625	797	629	797	711	674	855
Selling, General & Admin Expense	577	585	612	643	618	634	627	695	655	645	620
Research & Development Expense	146	-	-	-	-	-	-	-	-	-	-
Total Other Income / (Expense), net	-191	126	79	-9.00	-12	-129	45	100	322	-316	-125
Interest Expense	51	55	55	47	41	45	49	58	64	63	65
Other Income / (Expense), net	-140	181	134	38	29	-84	94	158	386	-253	-60
Income Tax Expense	152	-399	235	243	178	71	235	200	179	158	153
Net Income / (Loss) Attributable to Noncontrolling Interest	7.00	11	8.00	2.00	8.00	12	6.00	4.00	5.00	5.00	8.00
Basic Earnings per Share	$0.41	$1.19	$0.77	$0.58	$0.46	$0.44	$0.51	$0.41	$0.57	$0.25	($0.02)
Weighted Average Basic Shares Outstanding	990.75M	990.11M	989.53M	993.42M	998.00M	1.00B	1.01B	1.01B	1.01B	1.01B	1.01B
Diluted Earnings per Share	$0.40	$1.18	$0.77	$0.58	$0.45	$0.43	$0.51	$0.40	$0.57	$0.25	($0.02)
Weighted Average Diluted Shares Outstanding	990.75M	990.11M	989.53M	993.42M	998.00M	1.00B	1.01B	1.01B	1.01B	1.01B	1.01B
Weighted Average Basic & Diluted Shares Outstanding	990.75M	990.11M	989.53M	993.42M	998.00M	1.00B	1.01B	1.01B	1.01B	1.01B	1.01B
Cash Dividends to Common per Share	$0.23	$0.21	$0.21	$0.21	$0.21	$0.20	$0.20	$0.19	$0.19	$0.37	$0.18

This table details how cash moves in and out of Baker Hughes' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	718	158	-1,365	-279	883	-474	-3,307	5,997	-451	42
Net Cash From Operating Activities	3,332	3,062	1,888	2,374	1,304	2,126	1,762	-799	262	1,277
Net Cash From Continuing Operating Activities	3,332	3,062	1,888	2,374	1,304	2,126	1,762	-799	262	1,277
Net Income / (Loss) Continuing Operations	3,008	1,970	-578	-330	-15,761	271	283	-391	185	-631
Consolidated Net Income / (Loss)	3,008	1,970	-578	-330	-15,761	271	283	-391	185	-631
Depreciation Expense	1,136	1,087	1,061	1,105	1,317	1,418	1,486	1,103	550	530
Non-Cash Adjustments To Reconcile Net Income	-88	-399	1,089	1,057	15,355	245	153	11	0.00	2,080
Changes in Operating Assets and Liabilities, net	-724	404	316	542	393	192	-160	-1,522	-473	-702
Net Cash From Investing Activities	-1,016	-817	-1,564	-463	-618	-1,045	-578	-4,123	-472	-466
Net Cash From Continuing Investing Activities	-1,016	-817	-1,564	-463	-618	-1,045	-578	-4,123	-472	-466
Purchase of Property, Plant & Equipment	-1,278	-1,224	-989	-856	-974	-1,240	-995	-665	-424	-607
Acquisitions	0.00	-301	-767	-87	-57	-176	-530	-3,375	-16	-86
Sale of Property, Plant & Equipment	203	208	217	315	187	264	458	172	20	30
Divestitures	0.00	293	0.00	70	187	77	453	20	0.00	181
Sale and/or Maturity of Investments	92	372	26	147	-	-	-	-	-	-
Other Investing Activities, net	-33	-165	-51	-52	39	30	36	-275	-52	16
Net Cash From Financing Activities	-1,527	-2,028	-1,592	-2,143	225	-1,534	-4,363	10,919	-102	-515
Net Cash From Continuing Financing Activities	-1,527	-2,028	-1,592	-2,143	225	-1,534	-4,363	10,919	-102	-515
Repayment of Debt	-207	-704	-38	-2,210	469	-1,064	-1,067	-1,024	-293	193
Repurchase of Common Equity	-484	-538	-828	-434	0.00	-250	-2,486	-477	0.00	0.00
Payment of Dividends	-836	-786	-726	-749	-744	-745	-810	-406	0.00	0.00
Effect of Exchange Rate Changes	-71	-59	-97	-47	-28	-21	-128	-	-139	-254
Cash Interest Paid	298	309	291	-	-	-	-	109	55	52
Cash Income Taxes Paid	1,040	595	498	-	-	-	-	230	317	264

This table details how cash moves in and out of Baker Hughes' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-87	700	380	-433	71	-555	396	390	-73	-363	-77
Net Cash From Operating Activities	709	1,190	1,010	348	784	932	810	859	461	898	597
Net Cash From Continuing Operating Activities	709	1,190	1,010	348	784	932	810	859	461	898	597
Net Income / (Loss) Continuing Operations	409	1,191	773	581	463	451	524	414	581	188	-9.00
Consolidated Net Income / (Loss)	409	1,191	773	581	463	451	524	414	581	188	-9.00
Depreciation Expense	285	292	278	283	283	274	268	276	269	255	255
Non-Cash Adjustments To Reconcile Net Income	190	-71	-47	31	-1.00	49	-39	-84	-325	145	273
Changes in Operating Assets and Liabilities, net	-175	-222	6.00	-547	39	158	57	253	-64	310	78
Net Cash From Investing Activities	-310	-217	-269	-261	-269	-314	-89	-185	-229	-984	-150
Net Cash From Continuing Investing Activities	-310	-217	-269	-261	-269	-314	-89	-185	-229	-984	-150
Purchase of Property, Plant & Equipment	-300	-353	-300	-292	-333	-356	-281	-277	-310	-269	-226
Acquisitions	0.00	-	-	-	0.00	-	-19	-282	0.00	-681	-
Sale of Property, Plant & Equipment	45	58	44	50	51	58	63	41	46	28	46
Divestitures	0.00	-	-	-	0.00	-	-	293	0.00	-	-
Sale and/or Maturity of Investments	0.00	71	-	-	0.00	-	-	-	0.00	-	-
Other Investing Activities, net	-55	7.00	-34	-19	13	-16	-224	40	35	-62	4.00
Net Cash From Financing Activities	-502	-234	-364	-502	-427	-1,167	-311	-300	-250	-295	-429
Net Cash From Continuing Financing Activities	-502	-234	-364	-502	-427	-1,167	-311	-300	-250	-295	-429
Repayment of Debt	-85	-18	-3.00	-127	-59	-648	11	-9.00	-58	-4.00	18
Repurchase of Common Equity	-188	-8.00	-152	-166	-158	-319	-120	-99	0.00	-101	-265
Payment of Dividends	-229	-208	-209	-209	-210	-200	-202	-192	-192	-190	-182
Effect of Exchange Rate Changes	16	-39	3.00	-18	-17	-6.00	-14	16	-55	18	-95
Cash Interest Paid	50	99	49	102	48	104	48	107	50	101	50
Cash Income Taxes Paid	207	307	397	228	108	132	140	160	163	103	113

This table presents Baker Hughes' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016
Total Assets	38,363	36,945	34,181	35,308	38,007	53,369	52,439	56,500	21,721
Total Current Assets	17,211	16,301	14,592	15,065	16,455	15,222	14,971	18,424	7,401
Cash & Equivalents	3,364	2,646	2,488	-	4,132	-	-	-	981
Accounts Receivable	7,122	7,075	5,958	5,651	5,622	6,416	5,969	6,015	2,563
Inventories, net	4,954	5,094	4,587	3,979	4,421	4,608	4,620	4,507	3,224
Other Current Assets	1,771	1,486	1,559	1,582	2,280	949	659	872	633
Plant, Property, & Equipment, net	5,127	4,893	4,538	4,877	5,358	6,240	6,228	6,959	2,325
Total Noncurrent Assets	16,025	15,751	15,051	15,366	16,194	31,907	31,240	31,117	11,995
Goodwill	6,078	6,137	5,930	5,959	5,977	20,690	20,717	19,927	6,680
Intangible Assets	3,951	4,093	4,180	4,131	4,397	5,381	5,719	6,358	2,449
Noncurrent Deferred & Refundable Income Taxes	1,284	722	657	735	953	954	1,072	715	326
Other Noncurrent Operating Assets	4,712	4,799	4,284	4,541	4,867	4,882	3,732	4,117	2,540
Total Liabilities & Shareholders' Equity	38,363	36,945	34,181	35,308	38,007	53,369	52,439	56,500	21,721
Total Liabilities	21,308	21,426	19,656	18,562	19,765	18,870	17,426	18,090	6,866
Total Current Liabilities	12,991	12,991	11,075	9,128	10,227	10,014	9,020	9,227	4,934
Short-Term Debt	53	148	677	40	889	321	942	2,037	239
Accounts Payable	4,542	4,471	4,298	3,745	3,532	4,268	4,025	3,377	1,898
Current Deferred Revenue	5,672	5,542	3,822	3,232	3,454	2,870	1,765	1,775	1,596
Other Current Liabilities	2,724	2,830	2,278	2,111	2,352	2,555	2,288	2,038	1,201
Total Noncurrent Liabilities	8,317	8,435	8,581	9,434	9,538	8,856	8,406	8,863	1,932
Long-Term Debt	5,970	5,872	5,980	6,687	6,744	6,301	6,285	6,312	38
Noncurrent Deferred & Payable Income Tax Liabilities	83	176	229	127	186	51	143	490	880
Noncurrent Employee Benefit Liabilities	988	978	960	1,110	1,217	1,079	1,018	1,172	519
Other Noncurrent Operating Liabilities	1,276	1,409	1,412	1,510	1,391	1,425	960	889	495
Total Equity & Noncontrolling Interests	17,055	15,519	14,525	16,746	18,242	34,499	35,013	38,410	14,855
Total Preferred & Common Equity	16,895	15,368	14,394	14,830	12,893	21,929	17,465	14,277	14,688
Total Common Equity	16,895	15,368	14,394	14,830	12,893	21,929	17,465	14,277	14,688
Common Stock	25,896	26,983	28,126	27,375	24,613	23,565	18,659	15,083	0.00
Retained Earnings	-5,840	-8,819	-10,761	-10,160	-9,942	0.00	25	-103	0.00
Accumulated Other Comprehensive Income / (Loss)	-3,161	-2,796	-2,971	-2,385	-1,778	-1,636	-1,219	-703	-1,894
Noncontrolling Interest	160	151	131	1,916	5,349	12,570	17,548	24,133	167

This table presents Baker Hughes' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Total Assets	38,110	38,363	37,530	36,656	37,141	36,945	36,550	36,093	35,042	34,181	33,165
Total Current Assets	16,841	17,211	16,568	15,930	16,420	16,301	16,161	15,806	15,386	14,592	14,335
Cash & Equivalents	3,277	3,364	2,664	2,284	2,717	2,646	3,201	2,805	2,415	2,488	2,851
Accounts Receivable	6,710	7,122	6,920	7,051	6,873	7,075	6,505	6,418	6,291	5,958	5,583
Inventories, net	5,161	4,954	5,254	5,126	5,339	5,094	4,964	4,957	4,786	4,587	4,111
Other Current Assets	1,693	1,771	1,730	1,469	1,491	1,486	1,491	1,626	1,894	1,559	1,790
Plant, Property, & Equipment, net	5,168	5,127	5,150	4,951	4,931	4,893	4,768	4,723	4,513	4,538	4,381
Total Noncurrent Assets	16,101	16,025	15,812	15,775	15,790	15,751	15,621	15,564	15,143	15,051	14,449
Goodwill	6,126	6,078	6,167	6,105	6,114	6,137	6,048	6,074	5,916	5,930	5,435
Intangible Assets	3,927	3,951	3,995	4,019	4,055	4,093	4,104	4,124	4,123	4,180	3,980
Noncurrent Deferred & Refundable Income Taxes	1,363	1,284	649	676	730	722	687	670	663	657	701
Other Noncurrent Operating Assets	4,685	4,712	5,001	4,975	4,891	4,799	4,782	4,696	4,441	4,284	4,333
Total Liabilities & Shareholders' Equity	38,110	38,363	37,530	36,656	37,141	36,945	36,550	36,093	35,042	34,181	33,165
Total Liabilities	20,904	21,308	21,187	20,935	21,591	21,426	21,155	20,831	20,193	19,656	18,798
Total Current Liabilities	12,594	12,991	12,790	12,586	13,179	12,991	12,681	12,311	11,618	11,075	9,465
Short-Term Debt	55	53	52	34	147	148	802	797	684	677	43
Accounts Payable	4,465	4,542	4,431	4,649	4,595	4,471	4,123	4,154	4,263	4,298	3,800
Current Deferred Revenue	5,589	5,672	5,685	5,506	5,711	5,542	5,187	5,101	4,434	3,822	3,262
Other Current Liabilities	2,485	2,724	2,622	2,397	2,726	2,830	2,569	2,259	2,237	2,278	2,360
Total Noncurrent Liabilities	8,310	8,317	8,397	8,349	8,412	8,435	8,474	8,520	8,575	8,581	9,333
Long-Term Debt	5,969	5,970	5,984	5,861	5,859	5,872	5,857	5,847	5,975	5,980	6,612
Noncurrent Deferred & Payable Income Tax Liabilities	93	83	154	156	149	176	280	283	246	229	194
Noncurrent Employee Benefit Liabilities	985	988	991	984	984	978	952	968	932	960	1,020
Other Noncurrent Operating Liabilities	1,263	1,276	1,268	1,348	1,420	1,409	1,385	1,422	1,422	1,412	1,507
Total Equity & Noncontrolling Interests	17,206	17,055	16,343	15,721	15,550	15,519	15,395	15,262	14,849	14,525	14,367
Total Preferred & Common Equity	17,042	16,895	16,189	15,574	15,391	15,368	15,250	15,125	14,714	14,394	14,144
Total Common Equity	17,042	16,895	16,189	15,574	15,391	15,368	15,250	15,125	14,714	14,394	14,144
Common Stock	25,450	25,896	26,045	26,340	26,610	26,983	27,415	27,696	27,925	28,126	28,223
Retained Earnings	-5,438	-5,840	-7,019	-7,785	-8,364	-8,819	-9,258	-9,776	-10,185	-10,761	-10,943
Accumulated Other Comprehensive Income / (Loss)	-2,970	-3,161	-2,837	-2,981	-2,855	-2,796	-2,907	-2,795	-3,026	-2,971	-3,136
Noncontrolling Interest	164	160	154	147	159	151	145	137	135	131	223

This table displays calculated financial ratios and metrics derived from Baker Hughes' official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	9.11%	20.56%	3.19%	-0.98%	-13.14%	4.20%	33.17%	31.32%	-21.61%	0.00%
EBITDA Growth	16.20%	196.48%	-27.13%	113.45%	-665.66%	0.80%	165.74%	-10.99%	105.28%	0.00%
EBIT Growth	20.62%	947.81%	-62.31%	104.87%	-1,608.89%	9.63%	542.65%	-144.35%	1,310.53%	0.00%
NOPAT Growth	65.10%	105.52%	-2,982.35%	90.97%	-2,993.62%	-11.15%	318.83%	-184.18%	344.47%	0.00%
Net Income Growth	52.69%	440.83%	-75.15%	97.91%	-5,915.87%	-4.24%	172.38%	-311.35%	129.32%	0.00%
EPS Growth	56.02%	413.11%	-125.93%	98.17%	-6,504.35%	-48.89%	287.50%	0.00%	0.00%	0.00%
Operating Cash Flow Growth	8.82%	62.18%	-20.47%	82.06%	-38.66%	20.66%	320.53%	-404.96%	-79.48%	0.00%
Free Cash Flow Firm Growth	32.71%	105.03%	-2,814.15%	-77.49%	379.33%	-37.37%	106.39%	-85.25%	0.00%	0.00%
Invested Capital Growth	4.35%	1.06%	-4.72%	-9.76%	-42.59%	-1.67%	-3.05%	180.75%	0.00%	0.00%
Revenue Q/Q Growth	1.94%	3.78%	2.03%	-0.05%	-3.95%	0.35%	2.08%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	6.90%	4.68%	-22.65%	-31.49%	7.94%	-6.34%	32.94%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	8.76%	5.82%	-57.65%	-52.64%	7.55%	-14.14%	225.99%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	22.20%	7.25%	-2,309.02%	-586.05%	-0.93%	-34.07%	213.73%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	32.57%	15.41%	-34.42%	-215.79%	5.16%	-43.42%	385.86%	0.00%	0.00%	0.00%
EPS Q/Q Growth	33.63%	10.40%	-35.56%	-133.75%	8.68%	-48.89%	104.55%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	8.39%	1.12%	7.03%	20.08%	-42.91%	14.42%	283.88%	-524.22%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	38.11%	65.06%	-7,456.05%	-8.08%	-25.95%	-1.03%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	-0.01%	0.21%	2.88%	-1.28%	4.15%	-1.97%	-1.47%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	20.99%	20.59%	20.80%	19.75%	15.45%	18.59%	17.42%	17.67%	22.41%	26.94%
EBITDA Margin	16.53%	15.52%	6.31%	8.94%	-65.79%	10.10%	10.44%	5.23%	7.72%	2.95%
Operating Margin	11.07%	9.08%	5.60%	6.39%	-77.17%	4.51%	3.06%	-1.65%	3.49%	-0.83%
EBIT Margin	12.44%	11.26%	1.30%	3.55%	-72.15%	4.15%	3.95%	-1.19%	3.52%	-0.23%
Profit (Net Income) Margin	10.81%	7.72%	-2.73%	-1.61%	-76.12%	1.14%	1.24%	-2.28%	1.41%	-3.78%
Tax Burden Percent	92.13%	74.20%	-2,627.27%	-77.10%	103.68%	35.99%	41.62%	116.72%	51.68%	399.37%
Interest Burden Percent	94.28%	92.48%	8.03%	58.87%	101.77%	76.06%	75.30%	164.22%	77.83%	415.79%
Effective Tax Rate	7.87%	25.80%	2,727.27%	177.10%	0.00%	64.01%	37.94%	0.00%	48.32%	0.00%
Return on Invested Capital (ROIC)	14.70%	9.15%	-162.52%	-4.88%	-37.52%	1.01%	1.11%	-0.74%	3.34%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	20.32%	15.80%	705.16%	16.45%	-170.67%	-2.35%	-5.19%	-63.24%	17.87%	0.00%
Return on Net Nonoperating Assets (RNNOA)	3.76%	3.97%	158.82%	3.00%	-22.24%	-0.23%	-0.34%	-0.73%	-0.85%	0.00%
Return on Equity (ROE)	18.47%	13.11%	-3.70%	-1.89%	-59.77%	0.78%	0.77%	-1.47%	2.49%	0.00%
Cash Return on Invested Capital (CROIC)	10.45%	8.09%	-157.68%	5.38%	16.59%	2.70%	4.21%	-95.68%	-196.66%	0.00%
Operating Return on Assets (OROA)	9.20%	8.07%	0.79%	1.98%	-32.70%	1.87%	1.66%	-0.52%	2.12%	0.00%
Return on Assets (ROA)	7.99%	5.54%	-1.66%	-0.90%	-34.50%	0.51%	0.52%	-1.00%	0.85%	0.00%
Return on Common Equity (ROCE)	18.29%	12.99%	-3.45%	-1.49%	-39.46%	0.44%	0.33%	-0.80%	2.46%	0.00%
Return on Equity Simple (ROE_SIMPLE)	17.80%	12.82%	-4.02%	-2.23%	-122.24%	1.24%	1.62%	-2.74%	1.26%	0.00%
Net Operating Profit after Tax (NOPAT)	2,838	1,719	-31,133	-1,010	-11,185	387	435	-199	236	-97
NOPAT Margin	10.20%	6.74%	-147.16%	-4.93%	-54.02%	1.62%	1.90%	-1.16%	1.81%	-0.58%
Net Nonoperating Expense Percent (NNEP)	-5.62%	-6.65%	-867.68%	-21.33%	133.15%	3.36%	6.30%	62.50%	-14.53%	0.00%
Return On Investment Capital (ROIC_SIMPLE)	12.30%	7.98%	-146.98%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	79.01%	79.41%	79.20%	80.25%	84.55%	81.41%	82.58%	82.33%	77.59%	73.06%
SG&A Expenses to Revenue	8.83%	10.24%	11.86%	12.05%	11.61%	11.88%	11.80%	14.76%	14.72%	12.67%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	9.91%	11.50%	15.20%	13.36%	91.97%	14.09%	14.36%	19.33%	18.92%	27.76%
Earnings before Interest and Taxes (EBIT)	3,463	2,871	274	727	-14,938	990	903	-204	460	-38
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	4,599	3,958	1,335	1,832	-13,621	2,408	2,389	899	1,010	492
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.40	2.18	1.97	1.59	1.53	1.05	1.15	2.11	0.00	0.00
Price to Tangible Book Value (P/TBV)	5.91	6.53	6.61	4.97	7.84	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.46	1.31	1.34	1.15	0.95	0.97	0.88	1.75	0.00	0.00
Price to Earnings (P/E)	13.63	17.26	0.00	0.00	0.00	180.53	103.14	0.00	0.00	0.00
Dividend Yield	2.05%	2.34%	2.60%	3.17%	3.77%	4.00%	3.94%	67.92%	0.00%	0.00%
Earnings Yield	7.34%	5.80%	0.00%	0.00%	0.00%	0.55%	0.97%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.20	1.96	1.75	1.44	1.32	1.03	1.07	1.40	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	1.56	1.45	1.54	1.38	1.38	1.64	1.80	3.23	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	9.44	9.36	24.45	15.47	0.00	16.22	17.23	61.79	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	12.54	12.91	119.11	38.98	0.00	39.45	45.59	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	15.29	21.55	0.00	0.00	0.00	101.03	94.63	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	13.03	12.10	17.29	11.94	21.94	18.37	23.36	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	21.52	24.37	0.00	25.46	5.79	37.86	24.99	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.35	0.39	0.46	0.40	0.42	0.19	0.21	0.22	0.02	0.00
Long-Term Debt to Equity	0.35	0.38	0.41	0.40	0.37	0.18	0.18	0.16	0.00	0.00
Financial Leverage	0.19	0.25	0.23	0.18	0.13	0.10	0.07	0.01	-0.05	0.00
Leverage Ratio	2.31	2.37	2.22	2.10	1.73	1.52	1.48	1.47	1.46	0.00
Compound Leverage Factor	2.18	2.19	0.18	1.23	1.76	1.16	1.12	2.41	1.14	0.00
Debt to Total Capital	26.10%	27.95%	31.43%	28.66%	29.50%	16.10%	17.11%	17.86%	1.83%	0.00%
Short-Term Debt to Total Capital	0.23%	0.69%	3.20%	0.17%	3.44%	0.78%	2.23%	4.36%	1.58%	0.00%
Long-Term Debt to Total Capital	25.87%	27.26%	28.23%	28.49%	26.06%	15.32%	14.88%	13.50%	0.25%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.69%	0.70%	0.62%	8.16%	20.67%	30.57%	41.54%	51.61%	1.10%	0.00%
Common Equity to Total Capital	73.21%	71.35%	67.95%	63.18%	49.83%	53.33%	41.35%	30.53%	97.07%	0.00%
Debt to EBITDA	1.31	1.52	4.99	3.67	-0.56	2.75	3.03	9.29	0.27	0.00
Net Debt to EBITDA	0.58	0.85	3.12	1.57	-0.26	1.40	1.47	1.47	-0.70	0.00
Long-Term Debt to EBITDA	1.30	1.48	4.48	3.65	-0.50	2.62	2.63	7.02	0.04	0.00
Debt to NOPAT	2.12	3.50	-0.21	-6.66	-0.68	17.13	16.61	-42.00	1.17	0.00
Net Debt to NOPAT	0.94	1.96	-0.13	-2.85	-0.31	8.73	8.05	-6.63	-2.98	0.00
Long-Term Debt to NOPAT	2.10	3.42	-0.19	-6.62	-0.60	16.30	14.45	-31.75	0.16	0.00
Altman Z-Score	2.09	1.66	1.19	1.21	-0.32	1.36	1.32	1.48	0.00	0.00
Noncontrolling Interest Sharing Ratio	0.95%	0.94%	6.55%	20.76%	33.98%	43.33%	56.77%	45.62%	1.12%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.32	1.25	1.32	1.65	1.61	1.52	1.66	2.00	1.50	0.00
Quick Ratio	0.81	0.75	0.76	0.62	0.95	0.64	0.66	0.65	0.72	0.00
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	2,017	1,520	-30,207	1,113	4,944	1,032	1,647	-25,777	-13,915	0.00
Operating Cash Flow to CapEx	309.95%	301.38%	244.56%	438.82%	165.69%	217.83%	328.12%	-162.07%	64.85%	221.32%
Free Cash Flow to Firm to Interest Expense	10.19	7.04	-119.87	3.72	18.73	4.35	7.39	-196.77	-136.42	0.00
Operating Cash Flow to Interest Expense	16.83	14.18	7.49	7.94	4.94	8.97	7.90	-6.10	2.57	10.64
Operating Cash Flow Less CapEx to Interest Expense	11.40	9.47	4.43	6.13	1.96	4.85	5.49	-9.86	-1.39	5.83
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.74	0.72	0.61	0.56	0.45	0.45	0.42	0.44	0.60	0.00
Accounts Receivable Turnover	3.92	3.91	3.64	3.64	3.44	3.85	3.82	4.01	5.10	0.00
Inventory Turnover	4.38	4.18	3.91	3.92	3.88	4.21	4.14	3.66	3.15	0.00
Fixed Asset Turnover	5.55	5.41	4.49	4.01	3.57	3.82	3.47	3.70	5.63	0.00
Accounts Payable Turnover	4.88	4.62	4.17	4.52	4.49	4.68	5.10	5.36	5.35	0.00
Days Sales Outstanding (DSO)	93.10	93.25	100.14	100.35	106.11	94.82	95.60	91.13	71.51	0.00
Days Inventory Outstanding (DIO)	83.39	87.23	93.30	93.17	94.13	86.78	88.17	99.76	115.94	0.00
Days Payable Outstanding (DPO)	74.80	79.01	87.60	80.72	81.32	77.99	71.51	68.07	68.25	0.00
Cash Conversion Cycle (CCC)	101.69	101.47	105.84	112.80	118.92	103.61	112.27	122.82	119.19	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	19,714	18,893	18,694	19,620	21,743	37,872	38,517	39,729	14,151	0.00
Invested Capital Turnover	1.44	1.36	1.10	0.99	0.69	0.62	0.58	0.64	1.85	0.00
Increase / (Decrease) in Invested Capital	821	199	-926	-2,123	-16,129	-645	-1,212	25,578	14,151	0.00
Enterprise Value (EV)	43,409	37,052	32,636	28,340	28,609	39,051	41,165	55,553	0.00	0.00
Market Capitalization	40,590	33,527	28,336	23,550	19,759	23,108	20,113	30,101	0.00	0.00
Book Value per Share	$17.07	$15.27	$14.27	$14.31	$12.45	$21.35	$15.88	$12.47	$0.00	$0.00
Tangible Book Value per Share	$6.94	$5.11	$4.25	$4.57	$2.43	($4.03)	($8.16)	($10.48)	$0.00	$0.00
Total Capital	23,078	21,539	21,182	23,473	25,875	41,121	42,240	46,759	15,132	0.00
Total Debt	6,023	6,020	6,657	6,727	7,633	6,622	7,227	8,349	277	0.00
Total Long-Term Debt	5,970	5,872	5,980	6,687	6,744	6,301	6,285	6,312	38	0.00
Net Debt	2,659	3,374	4,169	2,874	3,501	3,373	3,504	1,319	-704	0.00
Capital Expenditures (CapEx)	1,075	1,016	772	541	787	976	537	493	404	577
Debt-free, Cash-free Net Working Capital (DFCFNWC)	909	812	1,706	2,124	2,985	2,280	3,170	4,204	1,725	0.00
Debt-free Net Working Capital (DFNWC)	4,273	3,458	4,194	5,977	7,117	5,529	6,893	11,234	2,706	0.00
Net Working Capital (NWC)	4,220	3,310	3,517	5,937	6,228	5,208	5,951	9,197	2,467	0.00
Net Nonoperating Expense (NNE)	-170	-251	-30,555	-680	4,576	116	152	192	51	534
Net Nonoperating Obligations (NNO)	2,659	3,374	4,169	2,874	3,501	3,373	3,504	1,319	-704	0.00
Total Depreciation and Amortization (D&A)	1,136	1,087	1,061	1,105	1,317	1,418	1,486	1,103	550	530
Debt-free, Cash-free Net Working Capital to Revenue	3.27%	3.18%	8.06%	10.36%	14.42%	9.56%	13.86%	24.47%	13.19%	0.00%
Debt-free Net Working Capital to Revenue	15.35%	13.56%	19.82%	29.15%	34.37%	23.19%	30.13%	65.39%	20.68%	0.00%
Net Working Capital to Revenue	15.16%	12.98%	16.62%	28.96%	30.08%	21.85%	26.01%	53.54%	18.86%	0.00%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$3.00	$1.93	($0.61)	($0.27)	($14.73)	$0.23	$0.46	($0.34)	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	990.11M	1.00B	1.01B	2.05B	1.04B	1.03B	1.04B	1.13B	0.00	0.00
Adjusted Diluted Earnings per Share	$2.98	$1.91	($0.61)	($0.27)	($14.73)	$0.23	$0.45	($0.34)	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	990.11M	1.00B	1.01B	2.05B	1.04B	1.03B	1.04B	1.13B	0.00	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	($0.34)	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	990.11M	1.00B	1.01B	2.05B	1.04B	1.03B	1.04B	1.13B	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	3,116	1,959	1,323	1,105	463	991	799	351	520	1,666
Normalized NOPAT Margin	11.20%	7.68%	6.25%	5.39%	2.23%	4.16%	3.49%	2.04%	3.97%	9.98%
Pre Tax Income Margin	11.73%	10.41%	0.10%	2.09%	-73.42%	3.16%	2.97%	-1.95%	2.74%	-0.95%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	17.49	13.29	1.09	2.43	-56.58	4.18	4.05	-1.56	4.51	-0.32
NOPAT to Interest Expense	14.34	7.96	-123.54	-3.38	-42.37	1.63	1.95	-1.52	2.32	-0.81
EBIT Less CapEx to Interest Expense	12.06	8.59	-1.98	0.62	-59.56	0.06	1.64	-5.32	0.55	-5.13
NOPAT Less CapEx to Interest Expense	8.91	3.26	-126.61	-5.19	-45.35	-2.49	-0.46	-5.28	-1.65	-5.61
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	27.79%	39.90%	-125.61%	-226.97%	-4.72%	274.91%	286.22%	-103.84%	0.00%	0.00%
Augmented Payout Ratio	43.88%	67.21%	-268.86%	-358.48%	-4.72%	367.16%	1,164.66%	-225.83%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Baker Hughes' official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.14%	7.76%	4.02%	13.05%	12.28%	15.73%	23.69%	25.12%	18.22%	7.66%	5.42%
EBITDA Growth	-2.61%	35.32%	24.72%	21.73%	-11.71%	26.66%	131.90%	395.33%	107.01%	-37.06%	-13.75%
EBIT Growth	-4.08%	49.21%	31.68%	29.61%	-17.23%	38.63%	286.60%	212.94%	228.29%	-47.70%	-24.28%
NOPAT Growth	15.00%	77.87%	44.73%	69.47%	40.86%	56.37%	3,031.94%	2,080.42%	180.53%	28.50%	-158.10%
Net Income Growth	-11.66%	163.86%	47.71%	40.34%	-20.31%	139.89%	5,922.22%	149.46%	626.25%	-44.05%	-156.25%
EPS Growth	-11.11%	174.42%	50.98%	45.00%	-21.05%	72.00%	2,650.00%	147.62%	0.00%	-39.02%	-300.00%
Operating Cash Flow Growth	-9.57%	27.68%	24.69%	-59.49%	70.07%	3.79%	35.68%	167.60%	540.28%	16.02%	43.51%
Free Cash Flow Firm Growth	-177.42%	-50.63%	21.40%	469.49%	-38.65%	-71.73%	-111.21%	-95.61%	40.75%	-46.49%	63.40%
Invested Capital Growth	5.91%	4.35%	4.57%	1.21%	-1.33%	1.06%	3.75%	1.51%	-4.25%	-4.72%	-8.57%
Revenue Q/Q Growth	-12.72%	6.60%	-3.24%	11.23%	-6.09%	2.91%	5.16%	10.48%	-3.20%	9.98%	6.38%
EBITDA Q/Q Growth	-21.18%	-15.20%	16.29%	19.59%	14.74%	-21.84%	13.50%	-13.27%	64.61%	43.10%	244.55%
EBIT Q/Q Growth	-27.66%	-20.49%	22.16%	27.71%	20.28%	-29.83%	20.24%	-18.45%	101.47%	95.69%	135.13%
NOPAT Q/Q Growth	-45.20%	40.24%	21.46%	24.53%	-16.14%	14.10%	42.23%	3.50%	-6.91%	2,239.48%	3.93%
Net Income Q/Q Growth	-65.63%	53.75%	33.22%	25.49%	2.66%	-13.93%	26.57%	-28.74%	209.04%	2,188.89%	98.92%
EPS Q/Q Growth	-66.10%	53.25%	32.76%	28.89%	-55.00%	-15.69%	27.50%	-29.82%	128.00%	1,350.00%	97.62%
Operating Cash Flow Q/Q Growth	-40.42%	17.82%	190.23%	-55.61%	-15.88%	15.06%	-5.70%	86.33%	-48.66%	50.42%	85.98%
Free Cash Flow Firm Q/Q Growth	-415.28%	220.75%	-141.70%	-50.89%	99.66%	292.24%	-402.15%	-94.71%	-8.00%	-23.75%	18.29%
Invested Capital Q/Q Growth	1.21%	-0.01%	1.98%	2.62%	-0.29%	0.21%	-1.30%	0.04%	2.13%	2.88%	-3.43%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	22.95%	20.78%	22.32%	20.87%	19.91%	21.19%	20.22%	20.76%	20.10%	22.62%	20.94%
EBITDA Margin	13.96%	15.45%	19.43%	16.16%	15.04%	12.31%	16.20%	15.01%	19.12%	11.24%	8.64%
Operating Margin	11.70%	9.03%	13.46%	11.67%	10.17%	9.53%	10.75%	8.14%	7.66%	11.21%	5.01%
EBIT Margin	9.52%	11.49%	15.40%	12.20%	10.63%	8.30%	12.17%	10.64%	14.42%	6.93%	3.89%
Profit (Net Income) Margin	6.36%	16.16%	11.20%	8.14%	7.21%	6.60%	7.89%	6.56%	10.16%	3.18%	-0.17%
Tax Burden Percent	72.91%	150.44%	76.71%	70.51%	72.23%	86.40%	69.04%	67.43%	76.45%	54.34%	-6.25%
Interest Burden Percent	91.67%	93.50%	94.83%	94.60%	93.99%	92.06%	93.94%	91.37%	92.23%	84.60%	68.90%
Effective Tax Rate	27.09%	-50.44%	23.29%	29.49%	27.77%	13.60%	30.96%	32.57%	23.55%	45.66%	106.25%
Return on Invested Capital (ROIC)	12.24%	19.59%	14.62%	11.57%	10.16%	11.17%	9.85%	6.75%	6.61%	6.73%	-0.34%
ROIC Less NNEP Spread (ROIC-NNEP)	7.63%	25.87%	16.39%	11.40%	9.93%	8.21%	10.71%	8.53%	12.98%	1.85%	-0.11%
Return on Net Nonoperating Assets (RNNOA)	1.41%	4.79%	3.53%	2.74%	2.46%	2.06%	2.61%	2.13%	3.21%	0.42%	-0.02%
Return on Equity (ROE)	13.65%	24.38%	18.15%	14.32%	12.61%	13.23%	12.47%	8.87%	9.82%	7.14%	-0.36%
Cash Return on Invested Capital (CROIC)	9.43%	10.45%	7.58%	9.71%	11.09%	8.09%	4.98%	4.76%	3.45%	-157.68%	2.16%
Operating Return on Assets (OROA)	7.05%	8.49%	11.35%	9.07%	7.72%	5.95%	8.58%	7.10%	9.07%	4.22%	2.34%
Return on Assets (ROA)	4.71%	11.94%	8.26%	6.05%	5.24%	4.73%	5.56%	4.37%	6.40%	1.94%	-0.10%
Return on Common Equity (ROCE)	13.51%	24.14%	17.98%	14.18%	12.49%	13.11%	12.31%	8.77%	9.55%	6.68%	-0.33%
Return on Equity Simple (ROE_SIMPLE)	17.33%	0.00%	14.02%	12.96%	12.03%	0.00%	11.19%	7.76%	-0.52%	0.00%	-3.04%
Net Operating Profit after Tax (NOPAT)	548	1,000	713	587	472	562	493	347	335	360	-17
NOPAT Margin	8.53%	13.59%	10.33%	8.23%	7.35%	8.23%	7.42%	5.49%	5.86%	6.09%	-0.31%
Net Nonoperating Expense Percent (NNEP)	4.61%	-6.28%	-1.77%	0.17%	0.23%	2.96%	-0.86%	-1.78%	-6.36%	4.88%	-0.24%
Return On Investment Capital (ROIC_SIMPLE)	2.36%	4.34%	-	-	-	2.61%	-	-	-	1.70%	-
Cost of Revenue to Revenue	77.05%	79.22%	77.68%	79.13%	80.09%	78.81%	79.78%	79.24%	79.90%	77.38%	79.07%
SG&A Expenses to Revenue	8.98%	7.94%	8.86%	9.01%	9.63%	9.28%	9.44%	11.01%	11.46%	10.92%	11.55%
R&D to Revenue	2.27%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	11.25%	11.75%	8.86%	9.20%	9.74%	11.66%	9.47%	12.62%	12.44%	11.41%	15.92%
Earnings before Interest and Taxes (EBIT)	612	846	1,064	871	682	567	808	672	824	409	209
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	897	1,138	1,342	1,154	965	841	1,076	948	1,093	664	464
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.55	2.40	2.22	2.25	2.19	2.18	2.28	2.06	1.93	1.97	1.45
Price to Tangible Book Value (P/TBV)	6.23	5.91	5.96	6.44	6.46	6.53	6.82	6.33	6.09	6.61	4.35
Price to Revenue (P/Rev)	1.56	1.46	1.32	1.30	1.29	1.31	1.41	1.34	1.29	1.34	0.99
Price to Earnings (P/E)	14.87	13.63	16.04	17.63	18.50	17.26	20.60	27.09	0.00	0.00	0.00
Dividend Yield	1.96%	2.05%	2.30%	2.87%	2.39%	2.34%	2.24%	2.43%	2.63%	2.60%	3.57%
Earnings Yield	6.72%	7.34%	6.23%	5.67%	5.41%	5.80%	4.85%	3.69%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.33	2.20	2.00	2.01	1.97	1.96	2.03	1.84	1.72	1.75	1.35
Enterprise Value to Revenue (EV/Rev)	1.67	1.56	1.44	1.44	1.42	1.45	1.56	1.51	1.49	1.54	1.19
Enterprise Value to EBITDA (EV/EBITDA)	10.15	9.44	9.17	9.63	9.70	9.36	10.15	11.10	17.28	24.45	14.24
Enterprise Value to EBIT (EV/EBIT)	13.51	12.54	12.39	13.27	13.62	12.91	14.14	16.64	38.76	119.11	37.99
Enterprise Value to NOPAT (EV/NOPAT)	15.78	15.29	16.98	18.54	20.09	21.55	23.93	29.67	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	14.25	13.03	12.83	13.52	10.98	12.10	12.67	12.50	14.42	17.29	13.93
Enterprise Value to Free Cash Flow (EV/FCFF)	25.39	21.52	27.00	20.83	17.67	24.37	41.65	39.01	48.71	0.00	59.86
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.35	0.35	0.37	0.38	0.39	0.39	0.43	0.44	0.45	0.46	0.46
Long-Term Debt to Equity	0.35	0.35	0.37	0.37	0.38	0.38	0.38	0.38	0.40	0.41	0.46
Financial Leverage	0.18	0.19	0.22	0.24	0.25	0.25	0.24	0.25	0.25	0.23	0.21
Leverage Ratio	2.30	2.31	2.33	2.35	2.37	2.37	2.34	2.30	2.24	2.22	2.20
Compound Leverage Factor	2.11	2.16	2.21	2.22	2.23	2.18	2.20	2.10	2.06	1.88	1.51
Debt to Total Capital	25.93%	26.10%	26.97%	27.27%	27.86%	27.95%	30.19%	30.33%	30.96%	31.43%	31.66%
Short-Term Debt to Total Capital	0.24%	0.23%	0.23%	0.16%	0.68%	0.69%	3.64%	3.64%	3.18%	3.20%	0.20%
Long-Term Debt to Total Capital	25.70%	25.87%	26.74%	27.11%	27.18%	27.26%	26.56%	26.69%	27.78%	28.23%	31.45%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.71%	0.69%	0.69%	0.68%	0.74%	0.70%	0.66%	0.63%	0.63%	0.62%	1.06%
Common Equity to Total Capital	73.36%	73.21%	72.34%	72.05%	71.40%	71.35%	69.15%	69.05%	68.41%	67.95%	67.28%
Debt to EBITDA	1.32	1.31	1.40	1.46	1.57	1.52	1.76	2.10	3.50	4.99	3.86
Net Debt to EBITDA	0.60	0.58	0.78	0.89	0.86	0.85	0.91	1.21	2.23	3.12	2.20
Long-Term Debt to EBITDA	1.30	1.30	1.39	1.45	1.53	1.48	1.55	1.85	3.14	4.48	3.83
Debt to NOPAT	2.05	2.12	2.60	2.81	3.25	3.50	4.15	5.60	-38.29	-0.21	-5.15
Net Debt to NOPAT	0.93	0.94	1.45	1.72	1.78	1.96	2.16	3.24	-24.40	-0.13	-2.94
Long-Term Debt to NOPAT	2.03	2.10	2.58	2.80	3.17	3.42	3.65	4.93	-34.35	-0.19	-5.12
Altman Z-Score	1.97	1.86	1.70	1.63	1.49	1.45	1.49	1.34	1.27	1.21	1.02
Noncontrolling Interest Sharing Ratio	0.99%	0.95%	0.94%	0.92%	0.97%	0.94%	1.24%	1.12%	2.81%	6.55%	9.93%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.34	1.32	1.30	1.27	1.25	1.25	1.27	1.28	1.32	1.32	1.51
Quick Ratio	0.79	0.81	0.75	0.74	0.73	0.75	0.77	0.75	0.75	0.76	0.89
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-566	179	-149	356	726	363	-189	63	1,183	1,286	1,686
Operating Cash Flow to CapEx	278.04%	403.39%	394.53%	143.80%	278.01%	312.75%	371.56%	363.98%	174.62%	372.61%	331.67%
Free Cash Flow to Firm to Interest Expense	-11.09	3.26	-2.70	7.58	17.70	8.08	-3.86	1.08	18.48	20.41	25.94
Operating Cash Flow to Interest Expense	13.90	21.64	18.36	7.40	19.12	20.71	16.53	14.81	7.20	14.25	9.18
Operating Cash Flow Less CapEx to Interest Expense	8.90	16.27	13.71	2.26	12.24	14.09	12.08	10.74	3.08	10.43	6.42
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.74	0.74	0.74	0.74	0.73	0.72	0.71	0.67	0.63	0.61	0.60
Accounts Receivable Turnover	4.10	3.92	4.07	4.01	3.98	3.91	4.07	3.89	3.66	3.64	3.80
Inventory Turnover	4.18	4.38	4.22	4.26	4.11	4.18	4.28	4.08	3.91	3.91	4.01
Fixed Asset Turnover	5.51	5.55	5.50	5.59	5.55	5.41	5.37	5.04	4.73	4.49	4.43
Accounts Payable Turnover	4.85	4.88	5.04	4.88	4.70	4.62	4.91	4.64	4.35	4.17	4.50
Days Sales Outstanding (DSO)	89.05	93.10	89.75	90.93	91.67	93.25	89.76	93.89	99.62	100.14	96.01
Days Inventory Outstanding (DIO)	87.24	83.39	86.57	85.70	88.72	87.23	85.20	89.43	93.42	93.30	91.11
Days Payable Outstanding (DPO)	75.28	74.80	72.47	74.82	77.62	79.01	74.39	78.60	83.82	87.60	81.06
Cash Conversion Cycle (CCC)	101.01	101.69	103.85	101.81	102.77	101.47	100.58	104.72	109.23	105.84	106.06
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	19,953	19,714	19,715	19,332	18,839	18,893	18,853	19,101	19,093	18,694	18,171
Invested Capital Turnover	1.44	1.44	1.42	1.41	1.38	1.36	1.33	1.23	1.13	1.10	1.09
Increase / (Decrease) in Invested Capital	1,114	821	862	231	-254	199	682	284	-848	-926	-1,703
Enterprise Value (EV)	46,426	43,409	39,438	38,858	37,157	37,052	38,363	35,182	32,832	32,636	24,580
Market Capitalization	43,515	40,590	35,912	35,100	33,709	33,527	34,760	31,206	28,453	28,336	20,553
Book Value per Share	$17.21	$17.07	$16.30	$15.61	$15.42	$15.27	$15.10	$14.94	$14.55	$14.27	$13.88
Tangible Book Value per Share	$7.06	$6.94	$6.07	$5.46	$5.23	$5.11	$5.05	$4.87	$4.62	$4.25	$4.64
Total Capital	23,230	23,078	22,379	21,616	21,556	21,539	22,054	21,906	21,508	21,182	21,022
Total Debt	6,024	6,023	6,036	5,895	6,006	6,020	6,659	6,644	6,659	6,657	6,655
Total Long-Term Debt	5,969	5,970	5,984	5,861	5,859	5,872	5,857	5,847	5,975	5,980	6,612
Net Debt	2,747	2,659	3,372	3,611	3,289	3,374	3,458	3,839	4,244	4,169	3,804
Capital Expenditures (CapEx)	255	295	256	242	282	298	218	236	264	241	180
Debt-free, Cash-free Net Working Capital (DFCFNWC)	1,025	909	1,166	1,094	671	812	1,081	1,487	2,037	1,706	2,062
Debt-free Net Working Capital (DFNWC)	4,302	4,273	3,830	3,378	3,388	3,458	4,282	4,292	4,452	4,194	4,913
Net Working Capital (NWC)	4,247	4,220	3,778	3,344	3,241	3,310	3,480	3,495	3,768	3,517	4,870
Net Nonoperating Expense (NNE)	139	-190	-61	6.35	8.67	111	-31	-67	-246	172	-7.81
Net Nonoperating Obligations (NNO)	2,747	2,659	3,372	3,611	3,289	3,374	3,458	3,839	4,244	4,169	3,804
Total Depreciation and Amortization (D&A)	285	292	278	283	283	274	268	276	269	255	255
Debt-free, Cash-free Net Working Capital to Revenue	3.68%	3.27%	4.27%	4.05%	2.56%	3.18%	4.40%	6.38%	9.24%	8.06%	9.94%
Debt-free Net Working Capital to Revenue	15.45%	15.35%	14.03%	12.50%	12.93%	13.56%	17.42%	18.42%	20.20%	19.82%	23.69%
Net Working Capital to Revenue	15.26%	15.16%	13.84%	12.37%	12.37%	12.98%	14.16%	15.00%	17.10%	16.62%	23.49%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.41	$1.19	$0.77	$0.58	$0.46	$0.44	$0.51	$0.41	$0.00	$0.25	($0.02)
Adjusted Weighted Average Basic Shares Outstanding	990.75M	990.11M	989.53M	993.42M	998.00M	1.00B	1.01B	1.01B	1.01B	1.01B	1.01B
Adjusted Diluted Earnings per Share	$0.40	$1.18	$0.77	$0.58	$0.45	$0.43	$0.51	$0.40	$0.00	$0.25	($0.02)
Adjusted Weighted Average Diluted Shares Outstanding	990.75M	990.11M	989.53M	993.42M	998.00M	1.00B	1.01B	1.01B	1.01B	1.01B	1.01B
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	990.75M	990.11M	989.53M	993.42M	998.00M	1.00B	1.01B	1.01B	1.01B	1.01B	1.01B
Normalized Net Operating Profit after Tax (NOPAT)	548	662	713	597	477	703	494	415	378	360	353
Normalized NOPAT Margin	8.53%	8.98%	10.33%	8.37%	7.43%	10.29%	7.44%	6.58%	6.61%	6.09%	6.57%
Pre Tax Income Margin	8.73%	10.74%	14.61%	11.54%	9.99%	7.64%	11.43%	9.72%	13.30%	5.86%	2.68%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	12.00	15.38	19.35	18.53	16.63	12.60	16.49	11.59	12.88	6.49	3.22
NOPAT to Interest Expense	10.75	18.19	12.97	12.50	11.50	12.50	10.06	5.98	5.23	5.71	-0.26
EBIT Less CapEx to Interest Expense	7.00	10.02	14.69	13.38	9.76	5.98	12.04	7.52	8.75	2.67	0.45
NOPAT Less CapEx to Interest Expense	5.75	12.83	8.32	7.35	4.63	5.88	5.61	1.91	1.11	1.88	-3.03
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	28.94%	27.79%	36.49%	40.66%	43.41%	39.90%	46.46%	65.84%	-974.03%	-125.61%	-167.91%
Augmented Payout Ratio	46.34%	43.88%	71.53%	78.45%	80.99%	67.21%	65.20%	105.45%	-1,742.86%	-268.86%	-413.26%

Frequently Asked Questions About Baker Hughes' Financials

When does Baker Hughes's financial year end?

According to the most recent income statement we have on file, Baker Hughes' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Baker Hughes' net income changed over the last 9 years?

Baker Hughes' net income appears to be on a downward trend, with a most recent value of $3.01 billion in 2024, falling from -$631 million in 2015. The previous period was $1.97 billion in 2023. Check out Baker Hughes' forecast to explore projected trends and price targets.

What is Baker Hughes's operating income?

Baker Hughes's total operating income in 2024 was $3.08 billion, based on the following breakdown:

Total Gross Profit: $5.84 billion
Total Operating Expenses: $2.76 billion

How has Baker Hughes revenue changed over the last 9 years?

Over the last 9 years, Baker Hughes' total revenue changed from $16.69 billion in 2015 to $27.83 billion in 2024, a change of 66.8%.

How much debt does Baker Hughes have?

Baker Hughes' total liabilities were at $21.31 billion at the end of 2024, a 0.6% decrease from 2023, and a 210.3% increase since 2016.

How much cash does Baker Hughes have?

In the past 8 years, Baker Hughes' cash and equivalents has ranged from $0.00 in 2017 to $4.13 billion in 2020, and is currently $3.36 billion as of their latest financial filing in 2024.

How has Baker Hughes' book value per share changed over the last 9 years?

Over the last 9 years, Baker Hughes' book value per share changed from 0.00 in 2015 to 17.07 in 2024, a change of 1,707.4%.

Related Companies

This page (NASDAQ:BKR) was last updated on 5/30/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Baker Hughes (BKR) Financials

Frequently Asked Questions About Baker Hughes' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Baker Hughes (BKR) Financials

Annual Income Statements for Baker Hughes

Quarterly Income Statements for Baker Hughes

Annual Cash Flow Statements for Baker Hughes

Quarterly Cash Flow Statements for Baker Hughes

Annual Balance Sheets for Baker Hughes

Quarterly Balance Sheets for Baker Hughes

Annual Metrics And Ratios for Baker Hughes

Quarterly Metrics And Ratios for Baker Hughes

Frequently Asked Questions About Baker Hughes' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools